Review





Similar Products

g5 rt-cgm system  (Dexcom Inc)
90
Dexcom Inc g5 rt-cgm system
G5 Rt Cgm System, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g5 rt-cgm system/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
g5 rt-cgm system - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm aidex g7  (Microtech Medical Systems Inc)
90
Microtech Medical Systems Inc rt-cgm aidex g7
Rt Cgm Aidex G7, supplied by Microtech Medical Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm aidex g7/product/Microtech Medical Systems Inc
Average 90 stars, based on 1 article reviews
rt-cgm aidex g7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm g6  (Dexcom Inc)
90
Dexcom Inc rt-cgm g6
Rt Cgm G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm g6/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rt-cgm g6 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt‐cgm g6  (Dexcom Inc)
90
Dexcom Inc rt‐cgm g6
Rt‐Cgm G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt‐cgm g6/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rt‐cgm g6 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm systems dexcom g7  (Dexcom Inc)
90
Dexcom Inc rt-cgm systems dexcom g7
Rt Cgm Systems Dexcom G7, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm systems dexcom g7/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rt-cgm systems dexcom g7 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm  (MiniMed Inc)
90
MiniMed Inc rt-cgm
Main findings and highlights resulted by the systematic review
Rt Cgm, supplied by MiniMed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm/product/MiniMed Inc
Average 90 stars, based on 1 article reviews
rt-cgm - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm dexcom g4  (Dexcom Inc)
90
Dexcom Inc rt-cgm dexcom g4
Main findings and highlights resulted by the systematic review
Rt Cgm Dexcom G4, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm dexcom g4/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rt-cgm dexcom g4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rt-cgm dexcom g6  (Dexcom Inc)
90
Dexcom Inc rt-cgm dexcom g6
Rt-CGM/FGM in CH: population features, devices and study design
Rt Cgm Dexcom G6, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt-cgm dexcom g6/product/Dexcom Inc
Average 90 stars, based on 1 article reviews
rt-cgm dexcom g6 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Main findings and highlights resulted by the systematic review

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Main findings and highlights resulted by the systematic review

Article Snippet: Kasapkara et al. 2014 [ ] , n. 15 GSDIa, n. 1 GSDIb , Median age 7.6y (2-18y) , Rt-CGM , MiniMed (Medtronic), blinded , 72 h at baseline, after 3 and 6 months , Pre-post without control group (prospective) , Poor.

Techniques: Control

Rt-CGM/FGM in GSDs: population features, devices and study design

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Rt-CGM/FGM in GSDs: population features, devices and study design

Article Snippet: Kasapkara et al. 2014 [ ] , n. 15 GSDIa, n. 1 GSDIb , Median age 7.6y (2-18y) , Rt-CGM , MiniMed (Medtronic), blinded , 72 h at baseline, after 3 and 6 months , Pre-post without control group (prospective) , Poor.

Techniques: Control

Main findings and highlights resulted by the systematic review

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Main findings and highlights resulted by the systematic review

Article Snippet: Peeks et al. 2021 [ ] , 1°subset: n.1 GSDIa; 2° subset: n. 11 GSDs, 3° subset: n.3 GSDIb , 1°subset: 9y; 2°subset:2-22y; 3°subset: 2-11y , Rt-CGM , 1°, 3° subsets: Dexcom G6 (Dexcom), non-blinded; 2° subset Dexcom G4 (Dexcom), blinded , 1°subset: 5 days; 2°subset: 1 day; 3°subset: 30 days , 1° subset: case series (single case report); 2° subset: controlled intervention (prospective, randomized, double blind cross-over); 3° subset: pre-post without control group (retrospective) , 1° subset: fair; 2° subset: poor; 3° subset: poor.

Techniques: Control

Rt-CGM/FGM in GSDs: population features, devices and study design

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Rt-CGM/FGM in GSDs: population features, devices and study design

Article Snippet: Peeks et al. 2021 [ ] , 1°subset: n.1 GSDIa; 2° subset: n. 11 GSDs, 3° subset: n.3 GSDIb , 1°subset: 9y; 2°subset:2-22y; 3°subset: 2-11y , Rt-CGM , 1°, 3° subsets: Dexcom G6 (Dexcom), non-blinded; 2° subset Dexcom G4 (Dexcom), blinded , 1°subset: 5 days; 2°subset: 1 day; 3°subset: 30 days , 1° subset: case series (single case report); 2° subset: controlled intervention (prospective, randomized, double blind cross-over); 3° subset: pre-post without control group (retrospective) , 1° subset: fair; 2° subset: poor; 3° subset: poor.

Techniques: Control

Rt-CGM/FGM in CH: population features, devices and study design

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Rt-CGM/FGM in CH: population features, devices and study design

Article Snippet: Peeks et al. 2021 [ ] , 1°subset: n.1 GSDIa; 2° subset: n. 11 GSDs, 3° subset: n.3 GSDIb , 1°subset: 9y; 2°subset:2-22y; 3°subset: 2-11y , Rt-CGM , 1°, 3° subsets: Dexcom G6 (Dexcom), non-blinded; 2° subset Dexcom G4 (Dexcom), blinded , 1°subset: 5 days; 2°subset: 1 day; 3°subset: 30 days , 1° subset: case series (single case report); 2° subset: controlled intervention (prospective, randomized, double blind cross-over); 3° subset: pre-post without control group (retrospective) , 1° subset: fair; 2° subset: poor; 3° subset: poor.

Techniques: Biomarker Discovery, Control

Rt-CGM/FGM in CH: population features, devices and study design

Journal: Reviews in Endocrine & Metabolic Disorders

Article Title: Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications

doi: 10.1007/s11154-024-09903-y

Figure Lengend Snippet: Rt-CGM/FGM in CH: population features, devices and study design

Article Snippet: Worth et al. 2023 [ ] , n.9 CH , 2.1-17.7y , Rt-CGM , Decom G6 (Dexcom), blinded and not-blinded , 12weeks (0–4 w = blinded, 4–8 w = not-blinded, at week 8 Hypo-Cheat output, 8–12 w = blinded, 12 weeks expert review) , Observational (pilot study) , Poor.

Techniques: Biomarker Discovery, Control